AACR Virtual Meeting COVID-19 and Cancer February 3-5, 2021 DISCLOSURE OF FINANCIAL RELATIONSHIPS

In compliance with the standards set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the American Association for Cancer Research (AACR) that the information presented at CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the AACR has pro- vided information that planning committee members, speakers, and abstract presenters have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity.

Relationships are abbreviated as follows: E, Employee of listed company, G, Grant/research support recipient, A, Advisor or review panel member, C, Consultant, S, Stock Shareholder, SB, Speakers’ Bureau, H, Honoraria, O, Other.

Last Name First Name Company Relationships Type Role NIH-NHLBI (National Heart, Lung, and Altan-Bonnet Nihal No Relationships Speaker Blood Institute) Angus Derek University of Pittsburgh No Relationships Speaker Arthur Ronald American Association for Cancer Research No Relationships Staff Au Lewis The Francis Crick Institute No Relationships Speaker Gilead, , Baxter, Alexion, Ablynx, Fisher & Azoulay Elie Hôpital Saint Louis G,SB Speaker Payckle, Jazz Pharma, MSD Barker Anna Ellison Institute for Transformative Medicine No Relationships Program Committee AstraZeneca, Bayer, , Boehringer Ingelheim, Eli Lilly Oncology, F. Program Committee, Barlesi Fabrice INSERM U1030 - Gustave Roussy Institute Hoffmann, La Roche Ltd, Novartis, Merck, Mirati, H,O Speaker MSD, Pierre Fabre, Pfizer, Seattle Genetics, Takeda Program Committee, Bar-Sagi Dafna New York University Langone Medical Center No Relationships Speaker Bhalla Sheena Icahn School of Medicine at Mount Sinai No Relationships Speaker Program Committee, Bhattacharya Deepta University of Arizona Cancer Center Sana Biotechnology O Speaker

1 AACR Virtual Meeting COVID-19 and Cancer February 3-5, 2021 DISCLOSURE OF FINANCIAL RELATIONSHIPS

Last Name First Name Company Relationships Type Role Camacho-Rivera Marlene SUNY Downstate Health Sciences University No Relationships Speaker Program Committee, Carethers John University of Michigan No Relationships Speaker Chawla Sanjay Memorial Sloan Kettering Cancer Center No Relationships Speaker Chen Monica Columbia University No Relationships Speaker Chiorazzi Michael Yale School of Medicine No Relationships Speaker AstraZeneca PLC, BMS, Eisai Inc., , EMD Serono Inc., Exelixis Inc., GlaxoSmithKline PLC, Merck & Co., Inc., Choueiri Toni Dana-Farber Cancer Institute A,C,O Speaker Novartis International AG, Pfizer Inc., Kidney Cancer/GU Cancers, The COVID-19 and Cancer Consortium (CCC19) Cordovano Grace Enlightening Results, LLC No Relationships Speaker Crew Katherine Columbia University No Relationships Speaker Bristol Myers Squibb, Lilly, Pfizer, Daichii Curigliano Giuseppe University of Milan A Speaker Sankyo, AstraZeneca, Novartis, Veracyte, Ellipsis Daniels Bailee Huntsman Cancer Institute No Relationships Speaker Del Vecchio Fitz Catherine Reboot Rx No Relationships Speaker Dettorre Gino Imperial College London No Relationships Speaker UCSF Helen Diller Family Comprehensive Esserman Laura BCBSA, QLHC A,G Speaker Cancer Center Fadul Luiza Hospital de Base de São José do Rio Preto No Relationships Speaker Fajgenbaum David Perelman School of Med. Univ. of Pennsylvania No Relationships Speaker Feldman Jill EGFR Resisters No Relationships Speaker

2 AACR Virtual Meeting COVID-19 and Cancer February 3-5, 2021 DISCLOSURE OF FINANCIAL RELATIONSHIPS

Last Name First Name Company Relationships Type Role Aduro Biotech Inc., AstraZeneca/MedImmune, Bristol Myers Squibb, EMD Serono, Program Committee, Ferris Robert University of Pittsburgh Hillman Cancer Center MacroGenics, Inc., Merck, Novasenta, A,C,G,S,O Speaker Numab Therapeutics, Pfizer, Sanofi, Tesaro, Zymeworks, Inc. Eli Lilly, Boeringher Ingelheim, Otsuka Pharma, AstraZeneca, Novartis, Bristol Myers Squibb, Roche/, Pfizer, Celgene, Incyte, Inviata, Takeda, Tiziana Sciences, Clovis, Merck Serono, Bayer, MSD, GlaxoSmithKline S.p.A, Garassino Marina Fondazione IRCCS Istituto Nazionale dei Tumori Sanofi-Aventis, Spectrum Pharmaceuticals, G,O Speaker Blueprint Medicine, Seattle Genetics, Daiichi Sankyo, United Therapeutics, Merck KGaA, Janssen, MSD, Turning Point, Ipsen, MedImmune, Exelisis, Mirati Therapeutics, Regeneron Golden Todd National Cancer Institute No Relationships Speaker Gutierrez Cristina UT MD Anderson Cancer Center No Relationships Speaker Haikal Abdulah Wayne State University School of Medicine No Relationships Speaker Halpern Michael National Cancer Institute No Relationships Speaker PACT Pharma, Isoplexis, Indi Molecular, Sofie Heath James Institute for Systems Biology A Speaker Biosciences, Nanostring Hsu Patrick University of California, Berkeley No Relationships Program Committee Hyer Randall Inc. Moderna Inc. E Speaker Islam Jessica UNC Lineberger Comprehensive Cancer Center No Relationships Speaker

3 AACR Virtual Meeting COVID-19 and Cancer February 3-5, 2021 DISCLOSURE OF FINANCIAL RELATIONSHIPS

Last Name First Name Company Relationships Type Role Bristol Myers Squibb, Aduro Biotech, Lustgarten Foundation, Parker Institute for Cancer Jaffee Elizabeth Johns Hopkins University Immunotherapy, CStone, Dragonfly, Genocea, A,C,G,O Speaker Achilles, Adaptive Biotechnologies, Abmeta Biotech Jones Beth Yale University School of Medicine No Relationships Speaker Kamboj Mini Memorial Sloan Kettering Cancer Center No Relationships Speaker Karampera Christina Guy’s and St Thomas’ NHS Foundation Trust No Relationships Speaker Krogan Nevan UCSF School of Medicine No Relationships Speaker Krupinski Elizabeth Emory University School of Medicine No Relationships Speaker Kulasinghe Arutha Queensland University of Technology No Relationships Speaker NIH-NCATS (National Center for Advancing Kurilla Michael No Relationships Speaker Translational Sciences) Lamure Sylvain CHU Montpellier No Relationships Speaker Lavery Anita Queen’s University Belfast No Relationships Speaker Qiagen, Luxo, Imago, C4 Therapeutics, Isoplexis, Celgene, Roche, Prelude Therapeutics, Novartis, Janssen, Incyte, Gilead, Lilly, , Zentalis, A,C,G,H, Program Committee, Levine Ross Memorial Sloan Kettering Cancer Center Astellas, AstraZeneca, Constellation, Morphosys, S,SB,O Speaker Mana, Auron, Ajax, Bridge Therapeutics, Kurome, Mission Bio, Bristol Myers Squibb, Scorpion, Jubilant Perelman School of Medicine, University of Locci Michela No Relationships Speaker Pennsylvania Sidney Kimmel Medical College, Program Committee, Lopez Ana Maria No Relationships Thomas Jefferson University Speaker

4 AACR Virtual Meeting COVID-19 and Cancer February 3-5, 2021 DISCLOSURE OF FINANCIAL RELATIONSHIPS

Last Name First Name Company Relationships Type Role 7 Hills, Spring bank, Actym, Alphamab Oncology, Arch Oncology, Kanaph, Mavu, Onc. AI, Pyxis, Tempest, Abbvie, Alnylam, Array, Bayer, Bristol Myers Squibb, Checkmate, Cstone, Eisai, EMD Serono, KSQ, Janssen, Macrogenics, Luke Jason John UPMC Hillman Cancer Center Merck, Mersana, Nektar, Novartis, Pfizer, A,C,G,S,O Speaker Regeneron, Ribon, Rubius, Silicon, Synlogic, Tesaro, TRex, Werewolf, Xilio, Xencor, Agnios, Astellas, Corvus, Immatics, Incyte, Kadmon, Moderna, Numab, Repimmune, Takeda, Trishula, Tizuna Luo Jia Memorial Sloan Kettering Cancer Center Targeted Oncology H Speaker Mann Karely Huntsman Cancer Institute No Relationships Speaker FDA-CBER (Center for Biologics Evaluation Marks Peter No Relationships Speaker and Research) Mazarico Gallego Jose Maria Hospital Universitario 12 de Octubre No Relationships Speaker McCaskill-Stevens Worta National Cancer Institute No Relationships Speaker Compugen Inc., Innate Pharma Inc., Morphic Therapeutic, Myeloid Therapeutics, Celsius Program Committee, Merad Miriam Icahn School of Medicine at Mount Sinai A,C,G,O Therapeutics, Genentech Inc., Regeneron Inc., Speaker Boerhinger Ingelheim Inc. and Takeda Inc. PMV Pharma, Asher Biopharmaceutics, Mogg Robin Bill & Melinda Gates Medical Research Institute C Speaker Autobahn Therapeutics, Warburg Pincus Monroy-Iglesias Maria King’s College London No Relationships Speaker Moore Amy GO2 Foundation for Lung Cancer No Relationships Speaker

5 AACR Virtual Meeting COVID-19 and Cancer February 3-5, 2021 DISCLOSURE OF FINANCIAL RELATIONSHIPS

Last Name First Name Company Relationships Type Role Perelman School of Medicine, Program Committee, Morris Jeffrey No Relationships University of Pennsylvania Speaker Nekhlyudov Larissa Massachusetts General Hospital No Relationships Speaker Abbvie, Astellas, Celgene, Bristol Myers Squibb, Incyte, Karyopharm, Kite/Gilead, Merck, Miltenyi Biotec, MorphoSys, Novartis, Perales Miguel-Angel Memorial Sloan Kettering Cancer Center A,G,H,O Speaker Nektar Therapeutics, Omeros, Takeda, Cidara Therapeutics, Servier, Medigene, Neximmune, Be The Match, CIBMTR Perlman Stanley University of Iowa No Relationships Speaker Abbvie, Amgen, AstraZeneca, Bayer, Beigene, Biocartis, Boeringer Ingelheim, Bristol Myers Squibb, Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F. Hoffmann-La Roche, Foundation Medicine, Illumina, Incyte, Janseen, Merck Sharp Program Committee, Peters Solange Centre Hospitalier Universitaire Vaudois A,C,G,SB and Dohme, Merck Serono, Merrimack, Novartis, Speaker Pharma Mar, Phosphoplatin Therapeutics, Pfizer, Regeneron, Sanofi, Seattle Genetics, Takeda, Medscae, Prime, Biodesix, GlaxoSmithKline, Mirati Post Dean American Association for Cancer Research No Relationships Staff Reid Mary Roswell Park Comprehensive Cancer Center Johnson and Johnson Innovation G Speaker Amgen, 4C Biomed, Advaxis, Agilent, University of California Los Angeles, Jonsson Program Committee, Ribas Antoni AstraZeneca, Arcus, Kite-Gilead, Bristol Myers A,C,H,S,O Comprehensive Cancer Center Speaker Squibb Sahin Ugur BioNTech AG BioNTech AG E,S Speaker

6 AACR Virtual Meeting COVID-19 and Cancer February 3-5, 2021 DISCLOSURE OF FINANCIAL RELATIONSHIPS

Last Name First Name Company Relationships Type Role Sanjana Neville New York University Langone Medical Center No Relationships Speaker Sanoff Hanna UNC Lineberger Comprehensive Cancer Center No Relationships Speaker Shaya Justin UC San Diego Moores Cancer Center No Relationships Speaker Netherlands Comprehensive Cancer Organisation Siesling Sabine No Relationships Speaker (IKNL) Singer Dinah National Cancer Inst. No Relationships Speaker Spasic Marko Parker Institute for Cancer Immunotherapy Natera C Speaker Staudt Louis National Cancer Institute No Relationships Program Committee Steinmetz Nicole University of California, San Diego Mosaic IE Inc. A,C,S Speaker Sylva Rushan GSTT No Relationships Speaker Traina Tiffany Memorial Sloan Kettering Cancer Center No Relationships Speaker Surface Oncology, Leap Therapeutics, Cygnal Program Committee, Tuveson David Cold Spring Harbor Laboratory Therapeutics, Fibrogen, Merck, ONO, Chugai, A,C,G,S,SB,O Speaker Mestag Therapeutics Tworoger Shelley Moffitt Cancer Center No Relationships Speaker Santosha Vardhana Memorial Sloan Kettering Cancer Center Immunai, ADC Therapeutics C Speaker Adipudi Program Committee, Voigt Louis Memorial Sloan Kettering Cancer Center No Relationships Speaker Abramson Cancer Center of the University of Washington Armenta No Relationships Speaker Pennsylvania Waters Austin Huntsman Cancer Institute No Relationships Speaker

7 AACR Virtual Meeting COVID-19 and Cancer February 3-5, 2021 DISCLOSURE OF FINANCIAL RELATIONSHIPS

Last Name First Name Company Relationships Type Role Merck; Roche; Pieris; Elstar; Surface Oncology; Eli Lilly; Celgene; MedImmune; Bristol Myers Program Committee, Wherry John University of Pennsylvania C,G,H,S,O Squibb; Arsenal Biosciences; Arcus; DynaVax, Speaker KyMab Willman Cheryl UNM Comprehensive Cancer Center No Relationships Speaker Winkfield Karen Meharry-Vanderbilt Alliance No Relationships Speaker Winn Robert VCU Massey Cancer Center No Relationships Speaker Wise-Draper Trisha University of Cincinnati No Relationships Speaker Xie Zhuoer Mayo Clinic No Relationships Speaker Acerta, Novartis, Merrimack, Abbvie/ StemCentrx, Merck, Regeneron, Mirati Therapeutics, Janssen, AstraZeneca, Pfizer, OmniSeq, Personal Genome Diagnostics, Astellas, Sanofi-Aventis, Genomic Health, Zhang Tian Duke University School of Medicine A,C,G,SB Speaker Genentech/Roche, Exelis, Amgen, Bristol Myers Squibb, Pharmacyclics, Seattle Genetics, Dendreon, Calithera, Bayer, Foundation Medicine, IQVIA, MJH Associates, Pacific Genuity Transgene, Lytix Biopharma, Kaleido, Zitvogel Laurence Gustave Roussy A,G,S Speaker Everimmune

8